6 research outputs found

    μƒμ΄ν•œ μƒμš© μ†Œν”„νŠΈμ›¨μ–΄λ₯Ό μ‚¬μš©ν•œ CT κ΄€λ₯˜ λ§΅μ—μ„œμ˜ 경색 용적 μΈ‘μ •: κΈ‰μ„± λ‡Œμ‘Έμ€‘ ν™˜μžμ—μ„œ λ™μΌν•œ μ†ŒμŠ€ 데이터λ₯Ό μ‚¬μš©ν•œ μ •λŸ‰μ  뢄석

    Get PDF
    ν•™μœ„λ…Όλ¬Έ(석사) -- μ„œμšΈλŒ€ν•™κ΅λŒ€ν•™μ› : μ˜κ³ΌλŒ€ν•™ μ˜ν•™κ³Ό, 2021.8. μ†μ² ν˜Έ .연ꡬ λͺ©μ : CT κ΄€λ₯˜ μ˜μƒ (CT Perfusion map, CTP) κΈ‰μ„± ν—ˆν˜ˆμ„± λ‡Œμ‘Έμ€‘ ν™˜μžμ˜ 치료 μ—¬λΆ€μ˜ 선택 결정과정에 μ‹€μ œλ‘œ 널리 μ‚¬μš©λ˜κ³  μžˆμ§€λ§Œ, μ •ν™•ν•œ 경색 쀑심뢀 μš©μ μ„ μ˜ˆμΈ‘ν•˜λŠ” 데 μ‚¬μš©λ˜λŠ” 졜적의 μž„κ³„κ°’κ³Ό 맀개 λ³€μˆ˜μ— λŒ€ν•΄μ„œλŠ” λͺ…ν™•ν•œ ν‘œμ€€μ΄ μ—†λ‹€. ν˜„μž¬ rCBF <30 %의 μž„κ³„κ°’μ„ 가진 경색 쀑심뢀(Infarct core) 용적이 일반적으둜 μ‚¬μš©λ˜κ³  μžˆλ‹€. κ·ΈλŸ¬λ‚˜ Follow-up diffusion-weighted imaging (DWI)와 경색 쀑심뢀(Infarct core) 용적의 일치λ₯Ό ν‰κ°€ν•˜κΈ° μœ„ν•΄ CTP와 DWI μ‚¬μ΄μ˜ μ‹œκ°„κ°„κ²©μ΄ 24 μ‹œκ°„ 이내인 μ—¬λŸ¬ 연ꡬ가 μ§„ν–‰λ˜μ—ˆλ‹€. λ³Έ μ—°κ΅¬μ˜ λͺ©μ μ€ RAPID, singular value decomposition+ (SVD+) VITREA, BAYESIAN VITREA λ“±μ˜ CTP μ†Œν”„νŠΈμ›¨μ–΄ ν”„λ‘œκ·Έλž¨μ—μ„œ λ‹€μ–‘ν•œ Deconvolution 방법, 맀개 λ³€μˆ˜, μž„κ³„κ°’μ— 따라 μΈ‘μ •λœ 경색 쀑심뢀 용적과 짧은 μ‹œκ°„ κ°„κ²©μœΌλ‘œ (60λΆ„ 이내) μ‹œν–‰λœ DWIμ—μ„œ μΈ‘μ •λœ 경색 μ€‘μ‹¬λΆ€μš©μ κ³Όμ˜ μΌμΉ˜μœ¨μ„ ν‰κ°€ν•œλ‹€. 연ꡬ 방법: μ „λ°© μˆœν™˜μ— μžˆμ–΄μ„œ 큰 ν˜ˆκ΄€μ˜ 폐색증을 가진 42λͺ…μ˜ κΈ‰μ„± ν—ˆν˜ˆμ„± λ‡Œμ‘Έμ€‘ ν™˜μžκ°€ ν¬ν•¨λ˜μ—ˆλ‹€. CT κ΄€λ₯˜ μ˜μƒμ€ VITREA 및 RAPID의 SVD +와 Bayesian μ•Œκ³ λ¦¬μ¦˜μ„ ν¬ν•¨ν•œ λ‹€μ–‘ν•œ CT κ΄€λ₯˜ μ†Œν”„νŠΈμ›¨μ–΄λ‘œ μ²˜λ¦¬λ˜μ—ˆλ‹€. RAPIDλŠ” 경색 쀑심뢀λ₯Ό rCBF <20 % -38 %, rCBV <34 % -42 %을 가진 쑰직으둜 μ‹λ³„ν•˜μ˜€λ‹€. SVD+ VITREAμ—μ„œλŠ” 경색 쀑심뢀λ₯Ό CBV의 26-56 % κ°μ†Œλ‘œ μ •μ˜ν•˜μ˜€λ‹€. BAYESIAN VITREAμ—μ„œλŠ” 경색 쀑심뢀λ₯Ό CBV의 28-48% κ°μ†Œλ‘œ μ •μ˜ν•˜μ˜€λ‹€. Olea SphereλŠ” DWI 경색 쀑심뢀 μš©μ μ„ μΈ‘μ •ν•˜λŠ” 데 μ‚¬μš©λ˜μ—ˆλ‹€. CTP 쀑심뢀 용적의 츑정값은 DWIμ—μ„œ κ²°μ •λœ μ΅œμ’… 경색 용적과 λΉ„κ΅λ˜μ—ˆλ‹€. 연ꡬ κ²°κ³Ό: CTPλŠ” λͺ¨λ“  ν™˜μžμ—μ„œ DWI 전에 μ‹€μ‹œλ˜μ—ˆκ³ , CTP와 DWI μ‚¬μ΄μ˜ μ‹œκ°„μ˜ 쀑앙값은 37.5 λΆ„(min)μ΄μ—ˆλ‹€ interquartile range (IQR) 20 -44. 42 λͺ…μ˜ ν™˜μžμ—μ„œλŠ” μ΅œμ’… 경색 쀑심뢀 용적의 쀑앙값은 DWIμ—μ„œ 19.50 ml (IQR 6.91 - 69.72) μ˜€λ‹€. RAPID rCBF <30% κΈ°λ³Έ μ„€μ •κ°’μ—μ„œ 경색 쀑심뢀 용적 차이의 쀑앙값은 (IQR) 8.19 ml (3.95 – 30.70), spearman’s correlation coefficient (r) = 0.759λ₯Ό 얻을 수 μžˆμ—ˆμœΌλ©°; SVD+ VITREA CBV의 41% κ°μ†Œ μ‹œ 경색 쀑심뢀 용적 차이의 쀑앙값은 (IQR) 3.82 ml (-2.91 – 20.95), r = 0.717둜, BAYESIAN VITREA CBV의 38% κ°μ†Œ μ‹œ 경색 쀑심뢀 용적 차이의 쀑앙값은 (IQR) 8.16 ml (1.58 – 25.46), r = 0.754μ΄μ—ˆλ‹€. 반면 각 μ†Œν”„νŠΈμ›¨μ–΄μ— λŒ€ν•œ 졜적의 μž„κ³„κ°’μ€ 경색 쀑심뢀 μš©μ μ„ κΈ°λ³Έ 섀정보닀 μ •ν™•ν•˜κ²Œ μΆ”μ •ν•˜λŠ” κ²ƒμœΌλ‘œ μž…μ¦λ˜μ—ˆλ‹€. 각 μ†Œν”„νŠΈμ›¨μ–΄μ˜ κ°€μž₯ μ •ν™•ν•˜κ³  졜적의 경색 쀑심뢀 용적 차이의 μž„κ³„κ°’μ€ λ‹€μŒκ³Ό κ°™μ•˜λ‹€: RAPID rCBF <38 % 경색 쀑심뢀 용적 μ°¨μ΄λŠ” 4.87 ml (0.84 – 23.51), r = 0.752; SVD + VITREA CBV이 26 % κ°μ†Œ μ‹œ 경색 쀑심뢀 용적의 용적 차이가 -1.05 ml (-12.26 – 14.58), r = 0.679둜 λ‚˜νƒ€λ‚¬μœΌλ©°; BAYESIAN VITREA CBV의 28 % κ°μ†ŒλŠ” 경색 쀑심뢀 용적 차이가 5.23 ml (-2.90 – 22.91), r = 0.685μ˜€λ‹€. κ²°λ‘ : λ³Έ μ—°κ΅¬μ—μ„œλŠ” CBV μž„κ³„κ°’μ€ CBF μž„κ³„κ°’κ³Ό λΉ„κ΅ν•˜μ—¬ κΈ‰μ„± ν—ˆν˜ˆμ„± λ‡Œμ‘Έμ€‘ ν™˜μžμ˜ 경색 쀑심뢀 μš©μ μ„ μ˜ˆμΈ‘ν•˜λŠ” 더 μ •ν™•ν•œ 맀개 λ³€μˆ˜λ₯Ό μ œκ³΅ν•˜λŠ” κ²ƒμœΌλ‘œ λ‚˜νƒ€λ‚¬λ‹€.Purpose: Although using Computed Tomography Perfusion (CTP) for selecting and guiding decision-making processes of a patient with acute ischemic stroke has its advantages, there is no clear standardization of the optimal threshold and parameters used to predict infarct core volume accurately. Nowadays, infarct core volume with a rCBF<30% threshold is commonly used. However, several studies have been performed to assess the volumetric agreement of CTP infarct core volume with follow-up Diffusion-Weighted Imaging (DWI); the time between CTP and DWI was within 24 hours. In this study, we aimed to assess the volumetric agreement of estimated infarct core volume with different deconvolution methods, parameters, and thresholds on CTP software programs, including: RAPID, singular value decomposition plus (SVD+) VITREA, BAYESIAN VITREA, and also the final infarct volume on DWI with an especially short interval time (within 60 min) between CTP and follow-up DWI. Materials and methods: Forty-two acute ischemic stroke patients with occlusion of a large artery in the anterior circulation were included in the study. The CT perfusion maps were processed with different CT perfusion software, including SVD+ and Bayesian algorithms in VITREA and RAPID. The RAPID identified infarct core as tissue rCBF < 20-38% and rCBV < 34-42%. The SVD+ VITREA defined infarct core as CBV reduction of 26% - 56%. The Bayesian VITREA quantified infarct core as tissue CBV reduction of 28% - 48%. Olea Sphere was used to measure the infarct core volume on DWI. The CTP infarct core volume measurements were compared with the final infarct volume, which was determined on DWI. Results: The CTP was performed before DWI in all patients, and the median time between CTP and DWI was 37.5 minutes, with an interquartile range (IQR) of 20 – 44. In 42 patients, the median final infarct volume was 19.50 ml (IQR 6.91 – 69.72) with DWI. The most commonly used thresholds for each kind of CTP software, including RAPID rCBF<30%, resulted in a median infarct volume difference (IQR) of 8.19 ml (3.95 – 30.70), spearman’s correlation coefficient (r) = 0.759; SVD+ VITREA CBV reduction of 41% demonstrated a median infarct volume difference (IQR) of 3.82 ml (-2.91 – 20.95), r = 0.717; and BAYESIAN VITREA CBV reduction of 38% resulted in a median infarct volume difference (IQR) of 8.16 ml (1.58 – 25.46), r = 0.754. On the other hand, the optimal thresholds for each kind of software ended up estimating infarct core volume more accurately than the commonly used thresholds with lower infarct core volume differences. The most accurate and optimal infarct core volume thresholds for each kind of software were as follows: median infarct core volume difference (IQR) for RAPID rCBF<38% was 4.87 ml (0.84 – 23.51), r = 0.752; SVD+ VITREA CBV reduction of 26% was -1.05 ml (-12.26 – 14.58), r = 0.679; BAYESIAN VITREA CBV reduction of 28% was 5.23 ml (-2.90 – 22.91), r = 0.685. Conclusions: Our study found that the CBV thresholds provide a more accurate parameter to predict infarct core volume in acute ischemic stroke patients compared with the CBF thresholds.Chapter 1. Introduction 1 Chapter 2. Materials and methods 13 Chapter 3. Results 18 Chapter 4. Discussions 57 Chapter 5. Conclusions 64 Bibliography 65 Abstract in Korean 71석

    A Quantitative Comparison of Clinically Employed Parameters in the Assessment of Acute Cerebral Ischemia Using Dynamic Susceptibility Contrast Magnetic Resonance Imaging

    Get PDF
    Purpose: Perfusion magnetic resonance imaging (P-MRI) is part of the mismatch concept employed for therapy decisions in acute ischemic stroke. Using dynamic susceptibility contrast (DSC) MRI the time-to-maximum (Tmax) parameter is quite popular, but its inconsistently defined computation, arterial input function (AIF) selection, and the applied deconvolution method may introduce bias into the assessment. Alternatively, parameter free methods, namely, standardized time-to-peak (stdTTP), zf-score, and standardized-zf (stdZ) are also available, offering consistent calculation procedures without the need of an AIF or deconvolution.Methods: Tmax was compared to stdTTP, zf-, and stdZ to evaluate robustness of infarct volume estimation in 66 patients, using data from two different sites and MR systems (i.e., 1.5T vs. 3T; short TR (= 689 ms) vs. medium TR (= 1,390 ms); bolus dose 0.1 or 0.2 ml/kgBW, respectively).Results: Quality factors (QF) for Tmax were 0.54 Β± 0.18 (sensitivity), 0.90 Β± 0.06 (specificity), and 0.87 Β± 0.05 (accuracy). Though not significantly different, best specificity (0.93 Β± 0.05) and accuracy (0.90 Β± 0.04) were found for stdTTP with a sensitivity of 0.56 Β± 0.17. Other tested parameters performed not significantly worse than Tmax and stdTTP, but absolute values of QFs were slightly lower, except for zf showing the highest sensitivity (0.72 Β± 0.16). Accordingly, in ROC-analysis testing the parameter performance to predict the final infarct volume, stdTTP and zf showed the best performance. The odds for stdTTP to obtain the best prediction of the final infarct size, was 6.42 times higher compared to all other parameters (odds-ratio test; p = 2.2*10–16).Conclusion: Based on our results, we suggest to reanalyze data from large cohort studies using the parameters presented here, particularly stdTTP and zf-score, to further increase consistency of perfusion assessment in acute ischemic stroke

    Robust Low-Dose CT Perfusion Deconvolution via Tensor Total-Variation Regularization

    Get PDF
    Acute brain diseases such as acute strokes and transit ischemic attacks are the leading causes of mortality and morbidity worldwide, responsible for 9% of total death every year. Time is brain is a widely accepted concept in acute cerebrovascular disease treatment. Efficient and accurate computational framework for hemodynamic parameters estimation can save critical time for thrombolytic therapy. Meanwhile the high level of accumulated radiation dosage due to continuous image acquisition in CT perfusion (CTP) raised concerns on patient safety and public health. However, low-radiation leads to increased noise and artifacts which require more sophisticated and time-consuming algorithms for robust estimation. In this paper, we focus on developing a robust and efficient framework to accurately estimate the perfusion parameters at low radiation dosage. Specifically, we present a tensor total-variation (TTV) technique which fuses the spatial correlation of the vascular structure and the temporal continuation of the blood signal flow. An efficient algorithm is proposed to find the solution with fast convergence and reduced computational complexity. Extensive evaluations are carried out in terms of sensitivity to noise levels, estimation accuracy, contrast preservation, and performed on digital perfusion phantom estimation, as well as in vivo clinical subjects. Our framework reduces the necessary radiation dose to only 8% of the original level and outperforms the state-of-art algorithms with peak signal-to-noise ratio improved by 32%. It reduces the oscillation in the residue functions, corrects over-estimation of cerebral blood flow (CBF) and under-estimation of mean transit time (MTT), and maintains the distinction between the deficit and normal regions
    corecore